NCT07548034 Ultrasound-guided Needle Percutaneous Electrolysis With Therapeutic Exercise in Femoroacetabular Impingement Syndrome
| NCT ID | NCT07548034 |
| Status | Recruiting |
| Phase | — |
| Sponsor | CEU San Pablo University |
| Condition | Femoro Acetabular Impingement |
| Study Type | INTERVENTIONAL |
| Enrollment | 30 participants |
| Start Date | 2026-04-22 |
| Primary Completion | 2026-12-26 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 30 participants in total. It began in 2026-04-22 with a primary completion date of 2026-12-26.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Hip pain in the front of the hip is common and can make daily activities and sports difficult. One frequent cause is femoroacetabular impingement, also known as hip impingement. This clinical trial is studying whether adding ultrasound-guided percutaneous electrolysis - a minimally invasive physiotherapy technique that uses a fine needle and a small electrical current - to a program of specific exercises works better than doing the exercises alone. Participants will be randomly assigned to one of two groups: * One group will receive two sessions of percutaneous electrolysis plus a home exercise program. * The other group will follow the same home exercise program without percutaneous electrolysis. The study will last five weeks. Researchers will measure pain, hip movement, and hip function at the beginning, after one week, and after four weeks. They will also record any side effects. The main goal is to find out if adding percutaneous electrolysis helps reduce hip pain and improve function more than exercise alone. This pilot study will help determine if this technique could be a safe and effective non-surgical treatment option for people with pain in the front of the hip.
Eligibility Criteria
Inclusion Criteria: * Anterior hip pain (inguinal region) lasting more than 3 months * Numeric Rating Scale (NRS) pain score ≥ 4/10 during at least one provocative test * Positive result in at least one of the following clinical tests: Straight Leg Raise (SLR), Flexion-Adduction-Internal Rotation (FADIR), or Hip-External Rotation-Flexion-Ceiling (HEC) * Ultrasound findings compatible with pseudofibrotic tissue near the iliopsoas tendon at the anterosuperior acetabular recess * Age between 18 and 55 years * Able to provide written informed consent Exclusion Criteria: * Previous hip surgery * Moderate or severe hip osteoarthritis (diagnosed radiographically) * Neurological pathology affecting the lower limb * Dominant lumbar spine pathology * Active rheumatic or systemic inflammatory diseases * Any contraindication to percutaneous electrolysis * Belonephobia
Contact & Investigator
Guillermo Gallardo Lopez
PRINCIPAL INVESTIGATOR
CEU SP University
Frequently Asked Questions
Who can join the NCT07548034 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 55 Years, studying Femoro Acetabular Impingement. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07548034 currently recruiting?
Yes, NCT07548034 is actively recruiting participants. Contact the research team at guillermo.gallardolopez@usp.ceu.es for enrollment information.
Where is the NCT07548034 trial being conducted?
This trial is being conducted at Alcobendas, Spain.
Who is sponsoring the NCT07548034 clinical trial?
NCT07548034 is sponsored by CEU San Pablo University. The principal investigator is Guillermo Gallardo Lopez at CEU SP University. The trial plans to enroll 30 participants.